Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P 500
3,693.23
-64.76(-1.72%)
Dow 30
29,590.41
-486.29(-1.62%)
Nasdaq
10,867.93
-198.87(-1.80%)
Russell 2000
1,679.59
-42.72(-2.48%)
Crude Oil
79.43
-4.06(-4.86%)
Gold
1,651.70
-29.40(-1.75%)

Advertisement

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

62.86

-0.91

(-1.43%)

At close: 04:00PM EDT

62.96

+0.10

(+0.16%)

After hours:

07:28PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	63.77
Open	63.49
Bid	62.94 x 2200
Ask	63.10 x 1000
Day's Range	62.30 - 63.78
52 Week Range	57.17 - 74.12
Volume	7,603,791
Avg. Volume	6,694,436

Market Cap	78.85B
Beta (5Y Monthly)	0.39
PE Ratio (TTM)	261.92
EPS (TTM)	0.24
Earnings Date	Apr 27, 2022 - May 02, 2022
Forward Dividend & Yield	2.92 (4.89%)
Ex-Dividend Date	Jun 14, 2022
1y Target Est	69.48

All

Simply Wall St.
Institutional owners may take dramatic actions as Gilead Sciences, Inc.'s (NASDAQ:GILD) recent 4.2% drop adds to one-year losses
A look at the shareholders of Gilead Sciences, Inc. ( NASDAQ:GILD ) can tell us which group is most powerful. We can...
- Gogoro Inc.'s (NASDAQ:GGR) 17% loss last week hit both individual investors who own 51% as well as institutions
  Simply Wall St.
- Institutional investors may adopt severe steps after Airbnb, Inc.'s (NASDAQ:ABNB) latest 14% drop adds to a year losses
  Simply Wall St.
ACCESSWIRE
4 Questions With Dr. Javier Cortes: The Importance of Scientific Exchange To Advance Breast Cancer
NORTHAMPTON, MA / ACCESSWIRE / September 23, 2022 / Gilead Sciences For Dr. Javier Cortes, being a breast cancer researcher isn't just a profession - it's a calling. As the head of the International Breast Cancer Center (IBCC) in Madrid and Barcelona, ...
- Paid For By: Coastal Cosmetic & Plastic Surgery - Breast Cancer Awareness
  KZTV
- Pink Ribbon Meaning - The Story Behind Breast Cancer Ribbons
  TODAY
Motley Fool
Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond
Let's look at two biotech stocks that look attractive at current levels: AbbVie (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD). AbbVie is one of the largest pharmaceutical companies around. Like other drugmakers, AbbVie benefits from the fact that doctors do not stop prescribing lifesaving drugs even during challenging economic times, nor do patients stop taking them.
- AbbVie Inc.'s (NYSE:ABBV) Business Is Trailing The Market But Its Shares Aren't
  Simply Wall St.
- Is AbbVie a Buy?
  Motley Fool

Advertisement

S&P 5003,693.23-64.76(-1.72%)

Dow 3029,590.41-486.29(-1.62%)

Nasdaq10,867.93-198.87(-1.80%)

Russell 20001,679.59-42.72(-2.48%)

Crude Oil79.43-4.06(-4.86%)

Gold1,651.70-29.40(-1.75%)

Gilead Sciences, Inc. (GILD)

Chart Events

Performance Outlook

Institutional owners may take dramatic actions as Gilead Sciences, Inc.'s (NASDAQ:GILD) recent 4.2% drop adds to one-year losses

4 Questions With Dr. Javier Cortes: The Importance of Scientific Exchange To Advance Breast Cancer

Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond

S&P 500
3,693.23
-64.76(-1.72%)

Dow 30
29,590.41
-486.29(-1.62%)

Nasdaq
10,867.93
-198.87(-1.80%)

Russell 2000
1,679.59
-42.72(-2.48%)

Crude Oil
79.43
-4.06(-4.86%)

Gold
1,651.70
-29.40(-1.75%)